188 related articles for article (PubMed ID: 34298689)
1. RANBP2 Activates
Liu X; Chen X; Xiao M; Zhu Y; Gong R; Liu J; Zeng Q; Xu C; Chen X; Wang F; Cao K
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298689
[No Abstract] [Full Text] [Related]
2. Correction: Liu et al. RANBP2 Activates
Liu X; Chen X; Xiao M; Zhu Y; Gong R; Liu J; Zeng Q; Xu C; Chen X; Wang F; Cao K
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473437
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
4. Feedback Regulation of
Lin CH; Liao CC; Chen MY; Chou TY
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.
Jin L; Lu MH; Dai GC; Yao Q; Xiang H; Wang LX; Xue BX; Liu X
Neoplasma; 2020 Jul; 67(4):880-888. PubMed ID: 32305058
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of
Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
[TBL] [Abstract][Full Text] [Related]
8. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
9. The Essential Role of O-GlcNAcylation in Hepatic Differentiation.
Robarts DR; Kotulkar M; Paine-Cabrera D; Venneman KK; Hanover JA; Zachara NE; Slawson C; Apte U
bioRxiv; 2023 Feb; ():. PubMed ID: 36824917
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase inhibits the
Groves JA; Maduka AO; O'Meally RN; Cole RN; Zachara NE
J Biol Chem; 2017 Apr; 292(16):6493-6511. PubMed ID: 28232487
[TBL] [Abstract][Full Text] [Related]
11. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation regulates extracellular signal-regulated kinase (ERK) activation in Alzheimer's disease.
Ephrame SJ; Cork GK; Marshall V; Johnston MA; Shawa J; Alghusen I; Qiang A; Denson AR; Carman MS; Fedosyuk H; Swerdlow RH; Slawson C
Front Aging Neurosci; 2023; 15():1155630. PubMed ID: 37469955
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic β-cell hyper-O-GlcNAcylation leads to impaired glucose homeostasis
Jo S; Pritchard S; Wong A; Avula N; Essawy A; Hanover J; Alejandro EU
Front Endocrinol (Lausanne); 2022; 13():1040014. PubMed ID: 36387851
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation is a gatekeeper of porcine myogenesis.
Kirkpatrick LT; Daughtry MR; El-Kadi S; Shi TH; Gerrard DE
J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 36219104
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
[TBL] [Abstract][Full Text] [Related]
17. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation in cancer development and immunotherapy.
He XF; Hu X; Wen GJ; Wang Z; Lin WJ
Cancer Lett; 2023 Jul; 566():216258. PubMed ID: 37279852
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis.
Wang X; Feng Z; Wang X; Yang L; Han S; Cao K; Xu J; Zhao L; Zhang Y; Liu J
Diabetologia; 2016 Jun; 59(6):1287-96. PubMed ID: 26993634
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
